PROFESSIONAL PHARMACY SERVICES NOW AVAILABLE Wednesday 13 Aug 2014
Diabetes self manage A “QUASI-EXPERIMENTAL” study looking at the effects of a contextadapted diabetes self-management education and support project in the Phillippines on selfmanagement practices of people with diabetes found that such a project in resource-constrained settings, making use of human resources, might improve self management practices. It looked at 203 people with type 2 diabetes mellitus. CLICK HERE to read the study.
healthnotes.com.au
PHARMACYDAILY.COM.AU
Oxycodone treatment up THERE has been a “considerable increase” in the number of episodes of people receiving treatment for their own drug use where oxycodone was the principal drug of concern, according to a report by the Australian Institute of Health and Welfare (AIHW). The report found that from 200809 to 2012-13, while the proportion of episodes with licit opioids as a principal drug of concern had remained relatively stable at about 5%, episodes with oxycodone had increased from 305 to 1,140. This had coincided with a decrease in the proportion of episodes with morphine or methadone as a drug of concern. However an AIHW spokesperson said there was no analysis available as to whether this was a user shift. National Drug and Alcohol Research Centre researcher Professor Louisa Degenhardt said the AIHW report was not a complete picture for opioid
dependence as, as mentioned in the report, data for many drug replacement therapies was not included. The Illicit Drug Reporting System National Report 2013 found from 2012-13, those reporting injecting oxycodone most often in the last month rose slightly from 4% to 5%. Oxycodone comprised the third highest proportion of treatment episodes where licit opioids were the principal drug of concern at 16%, after morphine at 27% and methadone at 25%, AIHW said. This had grown from 5% in 200809, as had oxycodone prescriptions in the last decade, with an increase of about 152% from 2002-03 to 2007-08, the report found. Alcohol (41%), cannabis (24%), amphetamines (14%) and heroin (8%) were the most common principal drugs of concern. There were 108,910 clients receiving treatment from 714 agencies - CLICK HERE for more.
WIN WITH DESIGNER BRANDS This week Pharmacy Daily is giving five readers the chance to win Designer Brands’ latest foundation range.
Orthocell lists on ASX AUSTRALIAN regenerative medicine company Orthocell has listed on the Australian Securities Exchange (ASX) with ticker OCC. The company said it listed after raising $8m in an oversubscribed initial public offering, which would be used, among other things, to prepare for regulatory approvals of its stem cell therapy used to repair damaged tendons and ligaments, Ortho-ATI, in its first international market, either Europe or Japan. For more, CLICK HERE.
12–14 Sept 2014 Crown Conference and Events Centre, Melbourne
Each pack includes each of the new Designer Brands Flawless Finish Foundations: Lightweight Oil-Free Foundation - The secret to a radiant complexion, this oil-free foundation boasts light-to-medium coverage. Longwear 24 Hour Foundation - Make-up that goes the distance, this full coverage foundation boasts full coverage. Firming Age Revive Foundation - If you’re looking for younger looking skin, this buildable coverage foundation will help reduce the signs of ageing.
Three days focusing on your business at pharmacy’s most practical event!
Visit: www.dbcosmetics.com.au To win, be the first to send in the correct answer and your foundation shade to: comp@pharmacydaily.com.au.
What are the three variants available? Congratulations to yesterday’s winner Simonne Cramer from Scaffidi Group.
www.pharmacybusinessnetwork.com
Don’t just suppress hay fever and allergy symptoms. Ethical Nutrients Allergy Control is an exclusive, clinically trialled, non-drowsy formula that helps reduce the frequency and severity of allergy symptoms.
Always read the label. Use only as directed. If symptoms persist consult your healthcare professional.
Pharmacy Daily Wednesday 13th August 2014
t 1300 799 220
w www.pharmacydaily.com.au
page 1